Ibuprofen

Ibuprofen, the active ingredient in Ibuprofen, is a Nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It treats pain, fever and inflammation in adults and children when appropriate.

GNH USA supplies Ibuprofen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofen acts on inflammatory pathways to relieve symptoms across several common conditions.

- Pain relief: reduces mild to moderate nociceptive pain. - Fever reduction: lowers elevated body temperature. - Inflammation control: diminishes swelling in musculoskeletal injuries. - Arthritis: alleviates joint pain and stiffness in osteoarthritis and rheumatoid arthritis.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, or abdominal discomfort. - Headache: mild to moderate intensity. - Dizziness: transient sensation of light‑headedness. - Rash: mild skin erythema or itching.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulcer perforation. - Acute renal impairment or worsening of chronic kidney disease. - Severe allergic reactions such as anaphylaxis. - Hepatic injury: elevated liver enzymes or hepatitis. - Cardiovascular events: increased risk of thrombotic complications.

Before initiating ibuprofen therapy, consider the following safety measures.

- Assess renal function: monitor kidney health in patients with pre‑existing renal disease. - Evaluate gastrointestinal risk: avoid use in active ulcers or a history of serious GI bleeding. - Use the lowest effective dose: limit duration to reduce adverse event risk. - Caution in cardiovascular disease: weigh potential thrombotic risk. - Avoid in late pregnancy: discuss alternatives with an obstetrician. - Store at ambient temperature: keep below 25 °C in the original pack, protect from moisture.

Ibuprofen can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Lithium: elevated lithium serum concentrations. - Methotrexate: reduced clearance leading to toxicity. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding tendency. - ACE inhibitors: possible reduction in renal function.

Moderate Interactions (Monitor Closely):\n- Diuretics: may decrease renal clearance of ibuprofen. - Beta‑blockers: potential attenuation of antihypertensive effect.